Skip to main content

Transforming lives.* Incisionless therapy for movement disorders.

+25,000

Global
treatments**

Register here to receive invites to our webinars on the latest updates on focused ultrasound.

Essential Tremor1

Unilateral and staged, bilateral MR-guided focused ultrasound.

5-year study results demonstrate significant and sustained tremorimprovement.

Download the 5-year clinical summary results

73.8% Improvement in tremor severity at 5-years (CRST Part A).

Overall, focused ultrasound has been shown to be safe for treating essential tremor with minimal risk.

Most adverse events were mild and resolved in 6 months.

For complete safety data: https://insightec.com/safety-information

Reported adverse events following unilateral focused ultrasound treatment for essential tremor.

Refer your patients for focused ultrasound.

Download our referral brochure here

Revolutionary treatment for essential tremor, now approved to treat both sides.1

Download our referral brochure here

Announcing FDA approval of staged, bilateral pallidothalamic tractotomy to treat motor symptoms and complications of Parkinson’s disease.2

Stay informed – opt in to receive updates about this latest indication!

Parkinson’s Disease3

Unilateral MR-guided focused ultrasound for tremor dominant Parkinson’s disease.

53%

improvement in
functional disability
(CRST part C).

40%

improvement in quality
of life (QUEST).


Tremor-motor function significantly improved (CRST A+B composite)

Parkinson’s Disease4

MR-guided focused ultrasound for motor complications of Parkinson’s disease.

Unilateral MR-guided focused ultrasound pallidotomy is indicated for patients over 30 with confirmed diagnosis of idiopathic Parkinson’s disease.

Significant improvement,

in motor complications and motor symptom severity following focused ultrasound treatment of the GPi.

26.4%

Improvement in MDS-UPDRS Part III OFF at 3 months

46.1%

Improvement in MDS-UPDRS Part IV

No severe or life threatening events.

Primary efficacy responder analysis.

The most common complications reported by subjects in Insightec-sponsored clinical studies after treatment included: imbalance/gait disturbance, numbness/tingling, and headache/head pain. Additional infrequent events include dizziness, taste disturbance, slurred speech, fatigue and vomiting.

Persistent complications at three-years included: imbalance, unsteadiness, gait disturbance, musculoskeletal weakness and numbness/tingling.

  1. P150038/S015
  2. PMA50038/S037
  3. P150038/S006
  4. P150038/S014

*Referring to the significant improvement in quality of life.
** Insightec data on file

SAFETY INFORMATION:

Focused ultrasound treatment has been shown to be safe for treating essential tremor and Parkinson’s Disease certain indications, but as with any medical procedure, there are risks. For safety information, please visit: https://insightec.com/safety-information/. For detailed approved indications please visit: https://insightec.com/regulatory-approvals/

Results may not be representative of all treatment outcomes.